May 25, 2023 Syros Presents Data from Phase 1/1b Clinical Trial of SY-5609 in Advanced Solid Tumors at ASCO Annual Meeting
Mar 2, 2023 Syros Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
Feb 23, 2023 Syros to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 2, 2023
